IP Verse

Patent opposition analysis in Infection Drugs industry

In the competitive field of Infection Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Infection Drugs technology and learn how to protect your intellectual property.

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
STRAWMAN LIMITED8
SANDOZ7
N.V. NUTRICIA7
TEVA7
GENERICS UK6
COOKE, RICHARD6
FRESENIUS KABI DEUTSCHLAND GMBH5
FRIESLANDCAMPINA NEDERLAND B.V.4
HGF LIMITED4
PFIZER INC.4

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
VIIV HEALTHCARE COMPANY17
GILEAD SCIENCES, INC.13
MERCK SHARP & DOHME LLC8
MERCK SHARP & DOHME CORP.8
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.7
N.V. NUTRICIA7
NESTEC S.A.7
GLAXOSMITHKLINE BIOLOGICALS SA6
INTERVET INTERNATIONAL B.V.6
GLAXOSMITHKLINE BIOLOGICALS S.A.6

Latest patents opposed in the Infection Drugs industry

Patent challenges are becoming increasingly common in the Infection Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Infection Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Infection Drugs industry

EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 13, 2024ZENTIVA K.S.
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 12, 2024KILBURN & STRODE LLP
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 11, 2024N.V. NEDERLANDSCH OCTROOIBUREAU
EP3583947Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZER INC.Jul 11, 2024SK BIOSCIENCE CO., LTD.
EP3432890Product, In Particular Nutritional Supplement, Animal Feed, Foodstuff, Drug, Cosmetic And/Or Animal Feed Supplement For Supplying At Least One Molecule That Bonds To A Vitamin D Receptor, And Method For The Production ThereofBÜTER, BERNDApr 12, 2024HERBONIS ANIMAL HEALTH GMBH
EP2742945Antimicrobial Locking Solutions Comprising Taurinamide Derivatives And Biologically Acceptable Salts And Acids, With The Addition Of Small Concentrations Of HeparinND PARTNERS, LLCMar 28, 2024TAUROPHARM GMBH
EP2913327Methylene Blue And Its Medical UsePROVEPHARM LIFE SOLUTIONSMar 7, 2024AERA A/S
EP3525775Arginine And Its Use As A T Cell ModulatorINSTITUTE FOR RESEARCH IN BIOMEDICINEMar 7, 2024HAMPTON KNOWLES LIMITED
EP2913327Methylene Blue And Its Medical UsePROVENCE TECHNOLOGIESMar 6, 2024J A KEMP LLP
EP3525775Arginine And Its Use As A T Cell ModulatorINSTITUTE FOR RESEARCH IN BIOMEDICINEJan 25, 2024COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

Top patents facing oppositions in Infection Drugs industry

To stay ahead in the competitive Infection Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Infection Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3494972Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANY9
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES, INC.5
EP3597216Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE. R. SQUIBB & SONS, L.L.C.5
EP2899193Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUÍMICA, S.A.5
EP4008357Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SA4
EP3127542Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE COMPANY4
EP3153526Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE4
EP3391890Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-CyclodextrinMERCK SHARP & DOHME LLC4
EP3096785Sep 9, 2020Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZER INC.3
EP3150586Jan 8, 2020Modulators Of Pharmacokinetic Properties Of TherapeuticsGILEAD SCIENCES, INC.3